• Friday, Dec 02, 2022
  • Last Update : 09:54 am

WHO jab experts want more AstraZeneca clot data from outside Europe

  • Published at 07:26 am April 23rd, 2021
File photo: A vial and syringe are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021 Reuters

The WHO’s Strategic Advisory Group of Experts (SAGE) on Immunisation updated their guidance on the use of AstraZeneca’s coronavirus jab, rewriting the section on precautions in light of data from Europe on clotting

The World Health Organization’s vaccine advisors called Thursday for more data on the incidence of blood clots in people who received the AstraZeneca Covid-19 vaccine outside Europe.

The WHO’s Strategic Advisory Group of Experts (SAGE) on Immunisation updated their guidance on the use of AstraZeneca’s coronavirus jab, rewriting the section on precautions in light of data from Europe on clotting.

“WHO continues to support the conclusion that the benefits of these vaccines outweigh the risks,” the UN agency stressed in a statement.

On April 7, SAGE said a link between AstraZeneca’s Covid-19 jabs and blood clots was plausible but unconfirmed, underlining that reported occurrences were “very rare.”

In light of evidence emerging from ongoing vaccination programs, they have updated their recommendations on the AstraZeneca jab, which is being deployed in 157 territories according to an AFP count.

SAGE said most clotting cases were reported in Britain and the European Union, with very few cases noted in other countries.

They said it was unknown whether there was a risk of clotting from the second dose of the vaccine, while recommending that those who suffered blood clots after their first injection should not be given the second dose of the two-shot vaccine.

‘Very rare syndrome’

“A very rare syndrome of blood clotting combined with low platelet counts, described as thrombosis with thrombocytopenia syndrome (TTS), has been reported around four to 20 days following vaccination,” the new guidance says.

“A causal relationship between the vaccine and TTS is considered plausible although the biological mechanism for this syndrome is still being investigated.

“Most of these cases were reported from the UK and the EU. There is considerable geographic variation with regards to the reported incidence, with very few cases reported from non-European countries, despite extensive use of the vaccine.

“An estimation of the risk outside Europe needs further data collection and analysis.”

The vaccine currently forms the backbone of the Covax scheme, which ensures that poorer countries can access doses, with donors covering the cost.

Covax has so far shipped more than 40.5 million Covid-19 vaccine doses to 118 participating territories.

The SAGE guidance said that data from Britain, dated March 31, suggested the risk of TTS was approximately one case per 250,000 vaccinated adults, while the rate in the EU was estimated at one in 100,000.

It said current data from Europe suggested that the risk might be higher in younger adults compared with older adults.

“No specific risk factors have yet been identified,” it said.

Incidence by region, age, sex

Whilst stressing that the benefit of vaccination against Covid-19 “far outweighs” the risks, the assessment may differ between countries.

“Countries should consider their epidemiological situation, individual and population-level risks, availability of other vaccines, and alternate options for risk mitigation,” the guidance said.

“The benefit-risk ratio is greatest in older age groups.

“It is currently unknown whether there is a risk of TTS following the second dose.”

The safety surveillance and monitoring section was also rewritten, recommending research into serious adverse events including cerebral venous sinus thrombosis and thrombotic events with thrombocytopenia.

It also called for research into the incidence of TTS by region, age and sex.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail